Evidence map›Paper›PMID 30456380›Full record

ArticleLife science alliance2018

Identification of

Sung-Jae Cha, Kyle Jarrod McLean, Marcelo Jacobs-Lorena

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life science alliance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. TargetingVaccines · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sung-Jae ChaDepartment of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID https://orcid.org/0000-0003-0468-1723
Kyle Jarrod McLeanDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Marcelo Jacobs-LorenaDepartment of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID https://orcid.org/0000-0003-0449-432X
Johns Hopkins University · USMassachusetts Institute of Technology · US

Funding

ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BELCHER, HAROLYN MILLICENT EDITH · 1985 to 2007
$37.3M
Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
Molecular mechanisms of Plasmodium fertilizationR01AI127405 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACOBS-LORENA, MARCELO · 2017 to 2021
$2.0M
Determinants of Plasmodium liver invasionR01AI080668 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACOBS-LORENA, MARCELO · 2009 to 2012
$1.5M
Characterization of Plasmodium GAPDH as a candidate for development of a malaria pre-erythrocytic vaccineR21AI123613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACOBS-LORENA, MARCELO · 2016 to 2017
$446k
NCRR NIH HHS M01 RR000052NIAID NIH HHS R01 AI080668NIAID NIH HHS R01 AI127405NIAID NIH HHS R21 AI123613NIGMS NIH HHS P41 GM103311
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30456380
PMCPMC6238388
OpenAlexW2892244483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.